Sign In
Buy LNSR
$5.66
-0.0800 (-1.39%)
At Close: Jun 22, 2026
LENSAR Reports Fourth Quarter and Full Year 2024 Results and Provides Business Update
07:00am, Thursday, 27'th Feb 2025
31 ALLY Robotic Cataract Laser Systems™ placed in Q4 2024, representing an 86% increase in ALLY placements in full year 2024 over 2023; Company's total installed systems increased to approximately 3
LENSAR to Report Fourth Quarter and Full Year 2024 Financial Results on Thursday, February 27, 2025
12:00pm, Wednesday, 19'th Feb 2025
ORLANDO, Fla., Feb. 19, 2025 (GLOBE NEWSWIRE) -- LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or “the Company”), a global medical technology company focused on advanced robotic laser solutions for th
Medical Devices Firm Lensar Surges Ahead On Robotic Technology
04:36am, Wednesday, 05'th Feb 2025
LENSAR, Inc. is rated a Strong Buy by the Quant system, Wall Street analysts, and me, due to its innovative cataract treatment technology and growing market share. The company's ALLY Robotic Cataract
LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
07:33pm, Monday, 03'rd Feb 2025
ORLANDO, Fla., Feb. 03, 2025 (GLOBE NEWSWIRE) -- LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or the “Company”) today announced that a majority of the independent members of LENSAR's board of direct
LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
06:08pm, Thursday, 02'nd Jan 2025
ORLANDO, Fla., Jan. 02, 2025 (GLOBE NEWSWIRE) -- LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or the “Company”) today announced that a majority of the independent members of LENSAR's board of direct
LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04:01pm, Monday, 09'th Dec 2024
ORLANDO, Fla., Dec. 09, 2024 (GLOBE NEWSWIRE) -- LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or the “Company”) today announced that a majority of the independent members of LENSAR's board of direct
LENSAR to Participate in the BTIG 4th Annual Ophthalmology Day
08:00am, Tuesday, 26'th Nov 2024
ORLANDO, Fla., Nov. 26, 2024 (GLOBE NEWSWIRE) -- LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or “the Company”), a global medical technology company focused on advanced robotic laser solutions for th
LENSAR, Inc. (LNSR) Q3 2024 Earnings Call Transcript
01:16am, Saturday, 09'th Nov 2024
LENSAR, Inc. (NASDAQ:LNSR ) Q3 2024 Earnings Conference Call November 7, 2024 8:30 AM ET Company Participants Cameron Radinovic - Investor Relations, Burns McClellan Nicholas Curtis - Chief Executive
LENSAR Reports Third Quarter 2024 Results and Provides Business Update
07:00am, Thursday, 07'th Nov 2024
24 ALLY Robotic Laser Cataract Systems™ placed in 3Q 2024 including 11 sales in EU and Southeast Asia; Robust backlog with 24 systems pending installation as of September 30, 2024
LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
06:32pm, Friday, 01'st Nov 2024
ORLANDO, Fla., Nov. 01, 2024 (GLOBE NEWSWIRE) -- LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or the “Company”) today announced that a majority of the independent members of LENSAR's board of direct
LENSAR to Report Third Quarter 2024 Financial Results on Thursday, November 7, 2024
07:00am, Thursday, 31'st Oct 2024
ORLANDO, Fla., Oct. 31, 2024 (GLOBE NEWSWIRE) -- LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or “the Company”), a global medical technology company focused on advanced robotic laser solutions for th
One Millionth Procedure Completed Using LENSAR's Cataract Laser Systems
08:00am, Tuesday, 08'th Oct 2024
ORLANDO, Fla., Oct. 08, 2024 (GLOBE NEWSWIRE) -- LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or the “Company”), a global medical technology company focused on advanced robotic laser solutions for th
LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
06:25pm, Tuesday, 01'st Oct 2024
ORLANDO, Fla., Oct. 01, 2024 (GLOBE NEWSWIRE) -- LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or the “Company”) today announced that a majority of the independent members of LENSAR's board of direct
LENSAR, Inc. (LNSR) Q2 2024 Earnings Call Transcript
12:15am, Saturday, 10'th Aug 2024
LENSAR, Inc. (NASDAQ:LNSR ) Q2 2024 Earnings Conference Call August 8, 2024 8:30 AM ET Company Participants Cameron Radinovic - IR Nicholas Curtis - CEO & Director Thomas Staab - CFO Conference Call P
3 Under-$10 Stocks With the Potential to Make You a Millionaire
10:00am, Friday, 05'th Jul 2024
Buying low-priced stocks with explosive potential is any investor's dream — but it's not easy. Many stocks trade under $10 in the market, yet not all are quality picks.
